An interventional study of CAVEAT in Post-traumatic Stress Disorder, sponsored by University of Lausanne Hospitals. Recruiting at 1 site in Switzerland. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-13.
Sponsored by University of Lausanne Hospitals · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Stress Disorders, Post-Traumatic with a site in Switzerland — 12 open to participants now, 13 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Switzerland.
Among the 42 studies in Stress Disorders, Post-Traumatic with a site in Switzerland, this one is the 27th largest by planned enrollment of the 34 interventional ones that give a count, is one of 4 that started in 2024, is one of 30 with no phase, reaches primary completion later than 3 of the 12 other live ones, and was the 30th registered.
2,685 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 603 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →12 of the 42 studies in Stress Disorders, Post-Traumatic with a site in Switzerland are open now. Recruiting first, the newest first:
St.Gallen University of Applied Sciences · Sites in Switzerland
Ages 18+
Eva Heim · Sites in Switzerland, Germany
Ages 17+
University Children's Hospital, Zurich · Sites in Switzerland, Germany
Ages 7–18 · Healthy volunteers
Laurent Gaucher · Sites in Switzerland
Ages 14+
University of Zurich · Sites in Switzerland
Ages 16+
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 417 Stress Disorders, Post-Traumatic studies recruiting now, 187 (45%) set no upper age limit and 204 (49%) stop at 75 or younger; 63 take children under 18; 89 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 69 across 2,199 interventional studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 62 across the 34 interventional studies, 650 across the 8 observational. Of the 25 that completed or were terminated, 2 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 42 have an industry lead sponsor. The 10 most frequent:
University of Lausanne Hospitals is the lead sponsor of 120 studies on the registry; 10 are open to participants now.
University of Lausanne Hospitals has 2 studies filed under Stress Disorders, Post-Traumatic — fewer than ten, so there is no comparison to draw.
4 of the studies in Stress Disorders, Post-Traumatic with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06776523University of ZurichBoosting Refugee Integration Through Psychological Intervention | 2026-12 |
| NCT06706323Roland von KänelDepressive Symptoms After Cardiac Surgery | 2027-04-01 |
| NCT07766265St.Gallen University of Applied SciencesNEST: A Group Intervention for Parents With Complex PTSD | 2027-10 |
| NCT04672551University of ZurichEMDR Treatment in PTSD Following Cardiac Events | 2027-11-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 42 studies in Stress Disorders, Post-Traumatic with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The first study proposed is a small (n= 10 to 12 maximum) open feasibility trial of CAVEAT which is a 16-session manualized brief psychotherapy prototcol that is designed to help mothers of infants and young children, whereby the mothers have been exposed to interpersonal violence (i.e. childhood maltreatment and family violence, intimate and non-intimate partner violence, interpersonal combat and or other forms of terrorism or political violence including physical and sexual assault) and who have developed related post-traumatic stress. The treatment uses an integration and extension of evidence-based techniques: Modified Interaction Guidance, Prolonged Exposure Therapy for PTSD, Child-Parent Psychotherapy, and Minding the Baby, in order to help mothers with post-traumatic dysregulation and difficulty in their maintaining sensitivity during challenging parent-child interactions (i.e. when mothers are confronted with child helpless states, emotion dysregulation, negative affect and child aggression). Outcome measures will initially include: maternal attributions towards her child (i.e. perception of child's personality), maternal-child behavior, and maternal-child symptoms of attachment disturbance and PTSD. This feasibility study is meant to perfect the manual and to prepare for an initial open trial with a larger clinical sample including analysis of pre- and post-intervention measures before further randomized control study can be done.
Risk / Benefit Assessment The risks of participating in this study are estimated as minimal (category A). The proposed intervention involves standard, validated psychotherapeutic procedures with the addition of clinician-assisted videofeedback exposure to naturalistic challenges that are typically stressful for young children and that are "in situation" by the clinician in collaboration with the child's mother during the filmed parent-child interaction sessions. This latter technique has been used without complication in both mental health referred and non-referred pediatrics samples with positive clinical effects in both studies. The investigators estimate that the risks of such an intervention are therefore limited. Though, if a matter arises that is severe, urgent or cannot be dealt with in the psychotherapy as conceived in the model, based on the therapist assessment, proper interventions and/or referrals will be made. Regarding the potential benefits
If this form of manualized psychotherapy proves feasible to administer in a public hospital outpatient mental health clinic for children, it could potentially be implemented for this group of patients in a study that tests its efficacy in terms of improvement in parental stress, maternal sensitivity, and reduction of parent-child relational disturbance, potentially benefitting the larger group of these difficult-to-treat child-parent dyads.
Objective(s) The aim of the submitted study is to determine whether the manualized, brief child-parent psychotherapy CAVEAT can be feasibly performed in a child and adolescent psychiatric ambulatory care center at the CHUV, a public university-hospital, this with child and mothers who have experienced IPV and who present to the clinic with concerns about their child's risk for emotional and/or behavior difficulties and/or who note relational disturbances with their very young children ages 1-5 years and/or problems with their parenting.
Aim 1: To assess the feasibility of the recruitment procedures and adherence to treatment among patients, mother, and child therapeutic alliance as well as in terms of the mother and child satisfaction.
Aim 2: To assess if CAVEAT evaluation measures (questionnaires and observed interactions) will be found appropriate, adequate, and sensitive by patients and therapists to the outcomes targeted Aim 3: To assess if CAVEAT for the therapists is feasible to administer in terms of the application of the psychotherapy manual and the psychotherapy procedures involved to the clinic population.
Study Design Open-trial feasibility study. Interim, and post-treatment measures of patient and therapist satisfaction and patient-therapist therapeutic alliance and agreement on treatment goals and realization of treatment objectives. Counts of number of completed sessions and drop-outs before completing the full course of therapy will be noted as well as the clinical supervisor's assessment of therapist adherence to the CAVEAT manual.
Statistical Considerations As this is an open feasibility study of 12 participant-dyads only, results will be in terms of descriptive statistics, counts, and percentages.
Control Intervention: There is no control group or intervention in this pilot feasibility study.
Study procedures As a feasibility study, the present study will implement and check the procedures related to recruitment; inclusion, retention vs drop-out; questionnaire completion and interviews; recording and transcription.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
CAVEAT active treatment group
Behavioral: CAVEAT
Brief psychotherapy with mothers of infants and young children, to which infants and young children attend many but not all sessions with mother
Treatment Satisfaction Questionnaire
Parental and Therapist individual self-report questionnaire
Time frame: through study completion, an average of 1 year
Parenting Stress Questionnaire-Short Form
Parental self-report questionnaire
Time frame: through study completion, an average of 1 year
Maternal Attributions Rating Scale
Clinician rating of parental attributions towards the child with scores ranging from 10-50, higher scores representing worse outcome (more negative and age-inappropriate attribution by clinician rating)
Time frame: through study completion, an average of 1 year
Plan to share: No — Yes
Started Jul 2024 (actual). Primary completion is estimated for Sep 2025, 14 months after the start.
Of 1,065 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 14 months is below that.
Counting every sponsor, half of 1,093 studies reached it within 34 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
University of Lausanne Hospitals →